Pancreatic Cancer section

Prostate Cancer News & Features

Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms

Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms

Meta-analysis of data from more than 50 studies reaffirms that vasectomy is not associated with increased risk of prostate cancer.

Obese Men at Higher Risk for Aggressive Prostate Cancer

Obese Men at Higher Risk for Aggressive Prostate Cancer

Study found taller and heavier males were more likely to develop prostate cancer, and they are also more likely to die of the disease.

Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years

Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years

Study results show that patients with prostate cancer express treatment decision regret, with concerns regarding sexual function, bowel function, and PSA most commonly associated with regret.

Metabolism of Next-Generation Prostate Cancer Drugs Share Similarities

Metabolism of Next-Generation Prostate Cancer Drugs Share Similarities

How the body metabolizes next-generation anti-androgen agents affects their anti-tumor activity in the treatment of prostate cancer.

Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care

Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care

Prostate-specific molecular imaging, such as PET and CT, can detect more cancer and improve patient care.

Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men

Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men

A survey of men with prostate cancer revealed that treatment-related factors impact treatment decisions differently in black men compared with white men.

Prehabilitation May Benefit Older Men Initiating ADT for Prostate Cancer

Prehabilitation May Benefit Older Men Initiating ADT for Prostate Cancer

Prehabilitation before initiating ADT in older men with prostate cancer may improve functioning, even in men on short-term ADT.

Better Understanding of Prostate Cancer Genetic Test Results Needed

Better Understanding of Prostate Cancer Genetic Test Results Needed

Some men who undergo multigene testing for inherited prostate cancer misinterpret findings of variants of uncertain significance.

Survival Increased With First-Line Abiraterone-ADT Combination for Hormone-Naïve Prostate Cancer

Survival Increased With First-Line Abiraterone-ADT Combination for Hormone-Naïve Prostate Cancer

Addition of abiraterone to androgen deprivation therapy for patients with hormone-naïve advanced prostate cancer may be a new standard of care.

Continued Enzalutamide Strategy Fails to Benefit mCRPC

Continued Enzalutamide Strategy Fails to Benefit mCRPC

Men who had PSA progression on enzalutamide but continued on the drug did not have improved PFS when abiraterone was added to their therapy.

Prostate Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs